Loading…
6 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Gamma+ | Oil & Gas | 18.8% | 89th pct | 135 |
| Trans Gas | Oil & Gas | 11.6% | 79th pct | 135 |
| Gamma | Oil & Gas | 9.2% | 76th pct | 135 |
| Invest 2023 | (unclassified) | 9.9% | 48th pct | 1208 |
| Biospero + | (unclassified) | — | no FY data | 1208 |
| Delta Gas | (unclassified) | — | no FY data | 1208 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 4 of 6 peers filed FY2024. Switch to FY2023 (5 of 6).
| Ratio — FY 2024 | Gamma+ | Gamma | Trans Gas | Invest 2023 | Biospero + | Delta Gas |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 38.9% | 35.9% | 35.6% | 73.3% | — | — |
| EBITDA Margin | 18.8% | 9.2% | 11.6% | 9.9% | — | — |
| EBITDAR | 1,622 | 704 | 235 | 86 | — | — |
| EBITDAR Margin | 19.1% | 10.9% | 12.0% | 9.9% | — | — |
| EBIT Margin | 17.7% | 6.4% | 8.9% | 7.1% | — | — |
| Net Profit Margin | 17.7% | 6.4% | 8.9% | 3.7% | — | — |
| Operating Expense % of Sales | 20.2% | 26.6% | 24.0% | 63.4% | — | — |
| Returns | ||||||
| Return on Assets (ROA) | 115.1% | 11.6% | 19.6% | 0.3% | — | — |
| Return on Equity (ROE) | 308.9% | |||||
| 12.9% |
| 21.1% |
| 0.3% |
| — |
| — |
| ROIC [EBIT / Invested Capital] | 357.6% | 15.1% | 21.7% | 0.6% | — | — |
| Leverage & debt balances | ||||||
| Debt-to-Assets | 25.3% | 0.0% | 0.0% | 0.0% | — | — |
| Debt-to-Equity | 0.68x | 0.00x | 0.00x | 0.00x | — | — |
| Debt-to-EBITDA | 0.21x | 0.00x | 0.00x | 0.00x | — | — |
| Equity-to-Assets | 37.3% | 90.1% | 93.1% | 99.8% | — | — |
| Net Debt | -64 | -467 | -25 | -20 | — | — |
| Cash & Equivalents | 395 | 467 | 25 | 20 | — | — |
| Total Debt | 330 | N/A | N/A | N/A | — | — |
| Liquidity & working capital | ||||||
| Current Ratio | 1.28x | 3.31x | 1.98x | 19.03x | — | — |
| Quick Ratio | 1.28x | 3.31x | 1.98x | 19.03x | — | — |
| Cash Ratio | 0.81x | 1.32x | 0.40x | 0.93x | — | — |
| Total Current Assets | 627 | 1,170 | 121 | 410 | — | — |
| Total Current Liabilities | 488 | 353 | 61 | 22 | — | — |
| Inventory | N/A | N/A | N/A | N/A | — | — |
| Trade Receivables | 64 | 673 | 50 | 274 | — | — |
| Trade Payables | 89 | 299 | 38 | 22 | — | — |
| Net Working Capital | 139 | 817 | 60 | 388 | — | — |
| Net Working Capital % of Revenue | 1.6% | 12.6% | 3.1% | 44.6% | — | — |
| Trade Working Capital | -25 | 374 | 12 | 252 | — | — |
| Trade Working Capital % of Revenue | -0.3% | 5.8% | 0.6% | 29.0% | — | — |
| Change in Trade Working Capital | N/A | N/A | N/A | N/A | — | — |
| Turnover & efficiency | ||||||
| Inventory Turnover | N/A | N/A | N/A | N/A | — | — |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A | — | — |
| Receivables Turnover | 131.96x | 9.63x | 39.05x | 3.18x | — | — |
| Days Sales Outstanding (DSO) | 2.8 | 37.9 | 9.3 | 114.9 | — | — |
| Payables Turnover | 58.25x | 13.89x | 33.01x | 10.81x | — | — |
| Days Payable Outstanding (DPO) | 6.3 | 26.3 | 11.1 | 33.8 | — | — |
| Cash Conversion Cycle | -3.5 days | 11.6 days | -1.7 days | 81.1 days | — | — |
| Asset Turnover | 6.52x | 1.81x | 2.19x | 0.08x | — | — |
| Cash flow & dividends | ||||||
| Operating Cash Flow | -152 | -152 | -134 | N/A | — | — |
| Free Cash Flow (OCF − Capex proxy) | -152 | -152 | -134 | N/A | — | — |
| Cash Conversion (OCF / EBITDA) | -9.5% | -25.4% | -58.7% | N/A | — | — |
| Dividends Declared | N/A | N/A | N/A | N/A | — | — |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | — | — |